Search

everythinglearnresearchcommunity

for

Search:↓

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Fish oil improves skin health in people with diabetes and high cholesterol.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Researchers found four genes that could help diagnose severe alopecia areata early.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

The African spiny mouse can fully regenerate its muscle without scarring, unlike the common house mouse.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Epidermal keratinocytes start wound healing and inflammation after schistosome infection.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

CD2 might be a new treatment target for patchy alopecia areata.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.